CELZ
Price
$2.16
Change
+$0.02 (+0.93%)
Updated
Apr 3, 02:31 PM (EDT)
Capitalization
5.43M
LABFF
Price
$90.61
Change
+$4.56 (+5.30%)
Updated
Jul 1 closing price
Capitalization
2.79B
Ad is loading...

CELZ vs LABFF

Header iconCELZ vs LABFF Comparison
Open Charts CELZ vs LABFFBanner chart's image
Creative Medical Technology Holdings
Price$2.16
Change+$0.02 (+0.93%)
Volume$300
Capitalization5.43M
LABORATORIOS FARMACEUTICOS ROVI SA
Price$90.61
Change+$4.56 (+5.30%)
Volume$100
Capitalization2.79B
CELZ vs LABFF Comparison Chart
Loading...
CELZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CELZ vs. LABFF commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CELZ is a Hold and LABFF is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (CELZ: $2.14 vs. LABFF: $90.61)
Brand notoriety: CELZ and LABFF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CELZ: 41% vs. LABFF: 100%
Market capitalization -- CELZ: $5.43M vs. LABFF: $2.79B
CELZ [@Biotechnology] is valued at $5.43M. LABFF’s [@Biotechnology] market capitalization is $2.79B. The market cap for tickers in the [@Biotechnology] industry ranges from $308.32B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CELZ’s FA Score shows that 0 FA rating(s) are green whileLABFF’s FA Score has 2 green FA rating(s).

  • CELZ’s FA Score: 0 green, 5 red.
  • LABFF’s FA Score: 2 green, 3 red.
According to our system of comparison, LABFF is a better buy in the long-term than CELZ.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CELZ’s TA Score shows that 4 TA indicator(s) are bullish.

  • CELZ’s TA Score: 4 bullish, 6 bearish.

Price Growth

CELZ (@Biotechnology) experienced а -3.17% price change this week, while LABFF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -7.56%. For the same industry, the average monthly price growth was -9.64%, and the average quarterly price growth was -14.03%.

Reported Earning Dates

CELZ is expected to report earnings on Aug 30, 2023.

Industries' Descriptions

@Biotechnology (-7.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LABFF($2.79B) has a higher market cap than CELZ($5.43M). LABFF YTD gains are higher at: 0.000 vs. CELZ (-7.359). LABFF has higher annual earnings (EBITDA): 208M vs. CELZ (-5.52M). LABFF has more cash in the bank: 27.4M vs. CELZ (6.26M). CELZ has less debt than LABFF: CELZ (2.74M) vs LABFF (114M). LABFF has higher revenues than CELZ: LABFF (764M) vs CELZ (11K).
CELZLABFFCELZ / LABFF
Capitalization5.43M2.79B0%
EBITDA-5.52M208M-3%
Gain YTD-7.3590.000-
P/E RatioN/A28.85-
Revenue11K764M0%
Total Cash6.26M27.4M23%
Total Debt2.74M114M2%
FUNDAMENTALS RATINGS
CELZ: Fundamental Ratings
CELZ
OUTLOOK RATING
1..100
67
VALUATION
overvalued / fair valued / undervalued
1..100
66
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
94
P/E GROWTH RATING
1..100
55
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CELZ
RSI
ODDS (%)
Bullish Trend 1 day ago
86%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
87%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 30 days ago
85%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
N/A
Aroon
ODDS (%)
Bearish Trend 1 day ago
88%
View a ticker or compare two or three
Ad is loading...
CELZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MCMVX19.190.22
+1.16%
Monongahela All Cap Value
CBBYX6.38N/A
N/A
AB Relative Value Advisor
OWSMX15.86N/A
N/A
Old Westbury Small & Mid Cap Strategies
IYPCX18.57N/A
N/A
Macquarie Systematic Em Mkts Eq R
GQHPX13.53N/A
N/A
GQG Partners US Quality Value Fund Inv

CELZ and

Correlation & Price change

A.I.dvisor indicates that over the last year, CELZ has been loosely correlated with LABFF. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if CELZ jumps, then LABFF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CELZ
1D Price
Change %
CELZ100%
+7.00%
LABFF - CELZ
35%
Loosely correlated
N/A
WVE - CELZ
30%
Poorly correlated
-2.20%
EDIT - CELZ
29%
Poorly correlated
+4.42%
GNPX - CELZ
28%
Poorly correlated
+28.21%
IMRN - CELZ
25%
Poorly correlated
N/A
More

LABFF and

Correlation & Price change

A.I.dvisor indicates that over the last year, LABFF has been closely correlated with IMRN. These tickers have moved in lockstep 81% of the time. This A.I.-generated data suggests there is a high statistical probability that if LABFF jumps, then IMRN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LABFF
1D Price
Change %
LABFF100%
N/A
IMRN - LABFF
81%
Closely correlated
N/A
MNMD - LABFF
47%
Loosely correlated
+7.76%
CELZ - LABFF
35%
Loosely correlated
+7.00%
NVO - LABFF
29%
Poorly correlated
+0.31%
QSI - LABFF
26%
Poorly correlated
+2.50%
More